21 – 30 of 32
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Production of hyperpolarized [1,4-13C2]malate from [1,4-13C2]fumarate is a marker of cell necrosis and treatment response in tumors
2009) In Proceedings of the National Academy of Sciences of the United States of America 106(47). p.6-19801(
- Contribution to journal › Article
-
Mark
Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors
(
- Contribution to journal › Article
-
Mark
The parametric response map is an imaging biomarker for early cancer treatment outcome
(
- Contribution to journal › Article
- 2008
-
Mark
Gene expression analysis of BCR/ABL1-dependent transcriptional response reveals enrichment for genes involved in negative feedback regulation.
(
- Contribution to journal › Article
-
Mark
Enterolactone is differently associated with estrogen receptor beta-negative and -positive breast cancer in a Swedish nested case-control study
(
- Contribution to journal › Article
- 2007
-
Mark
Estrogen receptor beta expression is associated with tamoxifen response in ER alpha-negative breast carcinoma
(
- Contribution to journal › Article
- 2006
-
Mark
Fine-needle aspiration of neurilemoma (schwannoma). A clinicocytopathologic study of 116 patients
(
- Contribution to journal › Article
- 2004
-
Mark
Serum cathepsin B activity during regression of Morris hepatoma 5123 D
(
- Contribution to journal › Article
- 2003
-
Mark
Characterization of a novel breast carcinoma xenograft and cell line derived from a BRCA1 germ-line mutation carrier
(
- Contribution to journal › Article
- 1999
-
Mark
Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer
(
- Contribution to journal › Article